Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity

Strahlentherapie und Onkologie

Volumn 183, Issue 7, 2007, Pages 385-391

  Nevinny Stickel, Meinhard ^a   Poljanc, Karin ^b   Forthuber, Britta C ^a   Heute, Dirk ^a   Posch, Andrea ^a   Lechner, Judith ^a   Beer, Beate ^a   Lukas, Peter ^a   Seppi, Thomas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TU WIEN   (Austria)

Author keywords

Dynamic renal scintigraphy; Paraaortic lymph node irradiation; Radiation induced nephropathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IRRADIATION; KIDNEY; KIDNEY PARENCHYMA; KIDNEY PLASMA FLOW; KIDNEY SCINTISCANNING; LYMAN WOLBARST ALGORITHM; NEPHROTOXICITY; PARAAORTIC LYMPH NODE; PATIENT MONITORING; PROTEINURIA; SCORING SYSTEM; UTERINE CERVIX CANCER;

ADULT; AGED; AORTA; CARCINOMA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; KIDNEY DISEASES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 34447123387     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1657-6     Document Type: Article

References (33)

1. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995;31:1249-56.
2. Cohen EP, Robbins ME. Radiation nephropathy. Semin Nephrol 2003;23:486-99.
3. Dörr W, Kost S, Keinert K, et al. Early intestinal changes following abdominal radiotherapy comparison of endpoints. Strahlenther Onkol 2006;182:1-8.
4. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-80.
5. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
6. Flentje M, Hensley F, Gademann G, et al. Renal tolerance to non-homogenous irradiation: comparison of observed effects to predictions of normal tissue complication probability from different biophysical models. Int J Radiat Oncol Biol Phys 1993;27:25-30.
7. Fossa SD, Aass N, Winderen M, et al. Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol 2002;13:222-3.
8. Igaki H, Karasawa K, Sakamaki H, et al. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks. Strahlenther Onkol 2005;181:704-8.
9. Inoue Y, Yoshikawa K, Yoshioka N, et al. Evaluating of renal function with 99m-Tc-MAG3 using semiautomated regions of interest. J Nucl Med 2000;41:1947-54.
10. Kim TH, Sommerville PJ, Freeman CR. Unilateral nephropathy - the long-term significance. Int J Radiat Oncol Biol Phys 1984;10:2053-9.
11. Kolbl O, Richter S, Flentje M. Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder. A prospective study using a 3-D planning system and a radiobiological model in patients receiving postoperative pelvic irradiation. Strahlenther Onkol 2000;176:105-11.
12. Kunkler PB, Farr, RF, Luxton RW. The limit of renal tolerance to X-rays. Br J Radiol 1952;25:190-201.
13. Luxton RW. Radiation nephritis. Q J Med 1953;22:215-42.
14. Lyman JT, Wolbart AB. Optimization of radiation therapy, IV. A dose-volume histogram reduction algorithm. Int J Radiat Oncol Biol Phys 1989;17:433-6.
15. Marnitz S, Köhler C, Füller J, et al. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol 2006;182:45-51.
16. Mayer A, Nemeskeri C, Petneházi C, et al. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. Strahlenther Onkol 2004;180:209-15.
17. Moiseenko V, Battista J, Van Dyk J. Normal tissue complication probabilities: dependence on choice of biological model and dose-volume histogram reduction scheme. Int J Radiat Oncol Biol Phys 2000;46:983-93.
18. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
19. Nevinny-Stickel M, Ennemoser S, Bangerl I, et al. Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites. Strahlenther Onkol 1998;174:341-4.
20. Nevinny-Stickel M, Seppi T, Poljanc K, et al. Competing irradiation techniques for para-aortic lymph nodes: dose distribution and NTCP for the kidney. Int J Radiat Oncol Biol Phys 2005;15:1206-13.
21. Niemierko A, Goietin M. Calculation of normal tissue complication probability and dose-volume reduction schemes for tissues with critical element architecture. Radiother Oncol 1991;20:166-76.
22. Olofsen-van Acht MJ, Quint S, Seven M, et al. Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer. Comparison between a conventional and a conformal technique. Strahlenther Onkol 1999;175:462-9.
23. Olsen DR, Kambestad BK, Kristoffersen DT. Calculation of radiation induced complication probabilities for brain, liver and kidney, and the use of a reliability model to estimate critical volume fractions. Br J Radiol 1994;67:1218-25.
24. Robbins MEC, Bonsib SM. Radiation nephropathy: a review. Scanning Microsc 1995;9:535-60.
25. Rotman M, Choi K, Guze C, et al. Prophylactic irradiation of the paraaortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 79-20. Int J Radiat Oncol Biol Phys 1990;19:513-21.
26. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
27. Russell CD, Dubovsky EV. Measurement of renal function with radionuclides. J Nucl Med 1989;30:2053-7.
28. Steward FA, Oussoren Y, Luts A, et al. Repair of sublethal radiation injury after multiple small doses in mouse kidney: an estimate of flexure dose. Int J Radiat Oncol Biol Phys 1987;13:765-72.
29. Varveris H, Kachris S, Mazonakis M, et al. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma. Strahlenther Onkol 2006;182:125-34.
30. Withers HR, Taylor JMG, Maciejewsky B. Treatment volume and tolerance. Int J Radiat Oncol Biol Phys 1987;14:751-9.
31. Yorke ED, Kutcher GJ, Jackson A, et al. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 1993;26:226-37.
32. Zaider M, Amols HI. Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization. Int J Radiat Oncol Biol Phys 1999;44:439-47.
33. Zaider M, Howards IA. A little to a lot to a little: is NTCP always minimized in multiport therapy? Int J Radiat Oncol Biol Phys 1998;41:945-50.